Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Topical Erythropoietin As a Novel Preventive and Therapeutic Agent in Bisphosphonate-Related Osteonecrosis of the Jaw Publisher



Nazeman P1 ; Rad MR1 ; Khojasteh A2
Authors

Source: Dental Hypotheses Published:2016


Abstract

Introduction: One of the most common side effects of bisphosphonate intake is osteonecrosis of the jaw (ONJ) which may develop following dentoalveolar interventions. Despite the vast available protocols, there is no clear guideline in the management of this condition. In osteonecrosis, the number and proliferation of bone-forming cells as well as vascularity are disturbed. Erythropoietin (EPO) is a hematopoietic hormone with angiogenic, osteogenic, and antiapoptotic properties. The Hypothesis: It is suggested to utilize poly lactic-co-glycolic acid hydrogel containing 1500-3000 IU/kg EPO following dentoalveolar surgery in samples receiving bisphosphonates as a preventive or therapeutic agent. Evaluation of the Hypothesis: Considering the pathophysiology of ONJ and therapeutic properties of EPO, it is assumed that EPO may be effective in treatment of ONJ. Furthermore, as a preventive measure, utilizing EPO following dentoalveolar surgery may be beneficial in the patients at risk of ONJ. © 2016 Dental Hypotheses | Published by Wolters Kluwer - Medknow.
Other Related Docs
10. Effects of Drugs and Chemotherapeutic Agents on Dental Implant Osseointegration: A Narrative Review, Current Reviews in Clinical and Experimental Pharmacology (2024)
18. Development of 166Ho-Pamidronate for Bone Pain Palliation Therapy, Journal of Radioanalytical and Nuclear Chemistry (2015)
20. Applications of Propolis in Dentistry: A Review, Ethiopian journal of health sciences (2018)